Pang Fuwan Uses Yao Medicine to Observe the Therapeutic Effects on the Physical and Mental Symptoms of Patients with Advanced Non-Small Cell Lung Cancer
- 1 Difficult and Miscellaneous Diseases of Yao Medicine Department, Yao Medicine Hospital of Jinxiu Yao Autonomous County, Laibin, China
- 2 Difficult and Miscellaneous Diseases of Yao Medicine Department, Yao Medicine Hospital of Jinxiu Yao Autonomous County, Laibin, China
- 3 Research Department, Yao Medicine Hospital of Jinxiu Yao Autonomous County, Laibin, China
Abstract
Objective: Investigate the efficacy and safety of Yao Medicine in the treatment of advanced non-small-cell lung carcinoma, and explore the best therapeutic measure for clinical benefit. Methods: From July 2020 to July 2022, 84 patients with advanced non-small-cell lung carcinoma were selected and randomly divided into the Observation Group and control group, and the control group was treated with routine Western medicine, with 42 cases in each group. The activity of daily living (ADL) was assessed before and after treatment, meanwhile, the self-rating depression scale (SDS) and self-rating anxiety SAS (SAS) were used to assess the improvement of a bad mood, and quality of life SF-36 was used to assess the quality of life, to judge the efficacy and safety. Results: The effective rate of observation group was 91.67%. The effective rate of the control group was 76.19%. The effective rate of the observation group was significantly higher than that of the control group (P < 0.05). There were no significant differences in the scores of SDS, SAS and quality of life between the two groups before treatment (P > 0.05), and after treatment, the scores of SDS, SAS and quality of life in the two groups were compared with those in the control group (P > 0.05), the scores of VAS, SDS and SAS decreased significantly, while ESCV, angle of straight leg elevation, ADL, physiological score, emotional score, social score and health status score increased significantly, the difference was statistically significant (P < 0.05). Conclusion: Yao Medicine can improve the psychosomatic symptoms of patients with advanced non-small-cell lung carcinoma better, with better efficacy and higher safety.
- Cheng, G., Jiang, X.D., Liu, H., et al. (2022) Efficacy and Safety of Arotinib Combined with Chemotherapy in Second-Line Treatment of Advanced Non-Small Cell Lung Cancer. Journal of Modern Oncology, 30, 2534-2538.
- Xiao, L., Wang, Z.W., et al. (2022) Analysis of TCM Syndromes and Related Factors after Anlotinib Treatment in Advanced Non-Small Cell Lung Cancer. Liaoning Journal of Traditional Chinese Medicine, 49, 74-78.
- Ma, H.J., Li, M., Li, J.F., et al. (2018) Clinical Study on the Treatment of Lumbar Disc herniation with Acupuncture Combined with Jintiange Capsules. International Journal of Traditional Chinese Medicine, 40, 26-29.
- Yi, D., Zhu, W., Meng, X.L., et al. (2020) Analysis of Anxiety, Depression and Related Factors in Patients with Chronic Lumbocrural Pain before Minimally Invasive Surgery. Journal of Peking University (Health Sciences), 52, 285-289.
- Qin, X.Y. and Li, T. (2001) Chinese Yao Medicine. Guangxi Nationalities Publishing House, Nanning.
- Li, T., Tang, N., Qin, S.J., et al. (2005) Practical Yao Medicine. China Medical Science and Technology Press, Beijing.
- Yu, J.F., Li, T., You, J.P., et al. (2019) Clinical Efficacy of Dumen Daoliao Therapy in Yao Medicine Combined with Acupuncture for Treatment of Cold-Dampness Lumbago. Guangxi Medical Journal, 41, 3106-3108.